WordNet

an impairment of health or a condition of abnormal functioning
caused by or altered by or manifesting disease or pathology; "diseased tonsils"; "a morbid growth"; "pathologic tissue"; "pathological bodily processes" (同)morbid, pathologic, pathological
of or relating to or resembling a cyst
of or relating to a normal cyst (as the gallbladder or urinary bladder)
either of two saclike respiratory organs in the chest of vertebrates; serves to remove carbon dioxide and provide oxygen to the blood
a closed sac that develops abnormally in some body structure

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity.

Di Lorenzo F1, Silipo A1, Bianconi I2, Lore' NI2, Scamporrino A3, Sturiale L3, Garozzo D3, Lanzetta R1, Parrilli M1, Bragonzi A2, Molinaro A4.
Molecular immunology.Mol Immunol.2015 Feb;63(2):166-75. doi: 10.1016/j.molimm.2014.04.004. Epub 2014 May 22.
Pseudomonas aeruginosa, the major pathogen involved in lethal infections in cystic fibrosis (CF) population, is able to cause permanent chronic infections that can persist over the years. This ability to chronic colonize CF airways is related to a series of adaptive bacterial changes involving the i
PMID 24856407

Biochemical Mechanisms and Therapeutic Potential of the Pseudohalide Thiocyanate in Human Health.

Chandler JD, Day BJ.
Free radical research.Free Radic Res.2015 Jan 7:1-40. [Epub ahead of print]
Abstract Thiocyanate (SCN-) is an ubiquitous molecule in mammalian biology, reaching up to mM concentrations in extracellular fluids. Two-electron oxidation of SCN- by H2O2 produces hypothiocyanous acid (HOSCN), a potent antimicrobial species. This reaction is catalyzed by chordate peroxidases (e.g.
PMID 25564094

Inhalation of macrolides: a novel approach to treatment of pulmonary infections.

Siekmeier R1, Hofmann T, Scheuch G.
Advances in experimental medicine and biology.Adv Exp Med Biol.2015;839:13-24. doi: 10.1007/5584_2014_50.
Systemic antibiotic treatment is established for many pulmonary diseases, e.g., cystic fibrosis (CF), bronchiectasis and chronic obstructive pulmonary disease (COPD) where recurrent bacterial infections cause a progressive decline in lung function. In the last decades inhalative administration of an
PMID 25252902